Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2023
Filter by date:
Showing 1239 press releases before 2023
-
Imfinzi plus chemotherapy approved in the US as the first immunotherapy regimen for patients with advanced biliary tract cancer
-
Evusheld long-acting antibody combination approved for prevention and treatment of COVID-19 in Japan
-
New data show Farxiga significantly lowers the risk of cardiovascular death in patients with heart failure
-
Farxiga significantly reduced the risk of cardiovascular death or worsening of heart failure in patients with mildly reduced or preserved ejection fraction in DELIVER Phase III trial
-
Ultomiris approved in Japan for the treatment of adults with generalised myasthenia gravis
-
Tagrisso approved in Japan for the adjuvant treatment of patients with early-stage EGFR-mutated lung cancer
-
Lynparza approved in Japan as adjuvant treatment for patients with BRCA-mutated HER2-negative high-risk early breast cancer
-
AstraZeneca aims to transform cancer outcomes with new data across industry-leading portfolio at ESMO 2022
-
Lynparza in combination with abiraterone granted Priority Review in the US for patients with metastatic castration-resistant prostate cancer
-
Enhertu significantly delayed disease progression in DESTINY-Breast02 Phase III trial vs. physician’s choice of treatment in patients with HER2-positive metastatic breast cancer
Latest articles and press releases
All of our latest press releases and articles are available to explore
